✦ LIBER ✦

Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients

✍ Scribed by Massimo Mascolo; Maria Luisa Vecchione; Gennaro Ilardi; Massimiliano Scalvenzi; Guido Molea; Maria Di Benedetto; Loredana Nugnes; Maria Siano; Gaetano De Rosa; Stefania Staibano

Book ID: 115010278
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 930 KB
Volume: 10
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-10-63

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overexpression of chromatin assembly fac

Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer

✍ Stefania Staibano; Massimo Mascolo; Francesco Paolo Mancini; Annamaria Kisslinge 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Assignment of the p60 Subunit of Chromat

Assignment of the p60 Subunit of Chromatin Assembly Factor I to Chromosome 21q22.2

✍ D.K. Shea; M. Rutter; D. Lucente; M.K. McCormick 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Mapping of the Gene for the p60 Subunit

Mapping of the Gene for the p60 Subunit of the Human Chromatin Assembly Factor (CAF1A) to the Down Syndrome Region of Chromosome 21

✍ Jean-Louis Blouin; Geneviève Duriaux-Sail; Haiming Chen; Arnaud Gos; Michael A. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 76 KB

The gene encoding the p60 subunit of chr

The gene encoding the p60 subunit of chromatin assembly factor I (CAF1P60) maps to human chromosome 21q22.2, a region associated with some of the major features of Down syndrome

✍ Nicholas Katsanis; E. M. C. Fisher 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 49 KB

Overexpression of the elongation factor

Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients

✍ Alessandra Bosutti; Bruna Scaggiante; Gabriele Grassi; Gianfranco Guarnieri; Gia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 305 KB

A phase I pharmacokinetic (PK) and seria

A phase I pharmacokinetic (PK) and serial tumor and skin pharmacodynamic (PD) study of weekly, every 2 weeks or every 3 weeks 1-hour (h) infusion EMD72000, an humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients (p) with advanced tumors known to overexpress the EGFR

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB